For people 2 years of age and older with active psoriatic arthritis

WE’RE COMMITTED TO MAKING COSENTYX® (secukinumab) AFFORDABLE AND ACCESSIBLE
Paying for IV Infusion
NEED HELP?: Give us a call, at 1-844-267-3689. If you need support starting or staying on COSENTYX, COSENTYX® Connect is here to help.
COVERAGE: Most insurers cover medications that are administered by your healthcare provider, such as COSENTYX infusions, under your medical insurance rather than through your prescription insurance.
CO-PAY SAVINGS: Co-pay support may be available to help with the cost of your infusion administration and COSENTYX prescription if you are eligible. That means if you have commercial or private prescription insurance, you may be eligible for co-pay support toward the cost of both COSENTYX and the administration.* Call 1-844-267-3689 for more information.
*Limitations apply. Subject to annual co-pay benefit limit. Offer not valid under Medicare, Medicaid, or any other federal or state programs. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions for details.
Paying for Self-Injection
We've got you covered
At COSENTYX® Connect, we are committed to helping make your medication as affordable as possible. A COSENTYX® Connect Team Member will help you understand your insurance coverage benefits and learn more about the options below that can help you pay for COSENTYX if you are eligible.

Actor Portrayal
84% of eligible patients who used the co-pay* program paid $0 out of pocket for COSENTYX.†
†2024 data on file.
Get up to 2 years of COSENTYX for free if eligible‡
The cost of biologics varies, based on certain factors. First, there’s the type of insurance you have and your prescription coverage. There are also differences in initial dosing, maintenance dosing, and the potential for dose adjustments. Because of all these factors, costs can vary.
The list (or wholesale) price for COSENTYX, as of January 2025 is $7,631.23 a month for either a 150-mg or a 300-mg dose strength self-injection package and $4,315.02 per intravenous infusion.§ The list price may not reflect the price paid by patients; most patients with prescription coverage will pay less.
§A month is defined as once every 4 weeks. Costs may vary depending on your condition, dosage, and how COSENTYX is taken. The price per IV infusion is for a patient weighing 165 lbs. to 310 lbs. Monthly costs and dosing for IV COSENTYX may vary depending on your body weight.
Novartis Patient Assistance Foundation
The Novartis Patient Assistance Foundation, Inc. (NPAF), a non-profit organization, is committed to providing access to Novartis medications for those most in need. If you are experiencing financial hardship, have limited or no prescription coverage, and cannot afford the cost of your medications, then you may be eligible to receive Novartis medications for free. To learn more, call 1-800-277-2254 or visit www.PAP.Novartis.com.

Questions about your insurance coverage?
If you’re enrolled in COSENTYX® Connect and you have changes in coverage or loss of insurance, or you are wondering about your co-pay, you can call COSENTYX® Connect at 1-844-COSENTYX (1-844-267-3689). You can also get more answers to insurance coverage questions and find helpful resources here or download the Insurance Coverage Questions brochure.

Individual results may vary. Brooke was compensated for her time.
“My insurance wouldn’t pay for COSENTYX. And then Novartis was nice enough to give me a year for free. So it was a relief not to have to worry about the insurance part of it.”
“You guys have been great about answering questions about my insurance and setting up delivery. I've had no problems at all with getting the medication.”

Individual results may vary. Dewey was compensated for his time.
Terms and Conditions
Co-Pay Plus Terms & Conditions
Offer valid only when used with commercial health insurance. Offer is not available where:
the patient has federal or state health plan benefits (eg, Medicare, Medicaid, TRICARE, VA);
the health plan reimburses for the entire cost of the drug;
the health plan provides no coverage for the drug; or
prohibited by law.
The amount of funding available from the Program is subject to an annual limit. Novartis reserves the right to discontinue the availability of co-pay assistance if, at any time, Novartis determines that the patient is subject to a co-pay maximizer program. Co-pay maximizers are programs implemented by health plans in which the amount of the patient’s out-of-pocket cost is increased to reflect the availability of support offered by a manufacturer assistance program. The patient is responsible for all costs once available funding from the Program is exhausted.
The Program is designed exclusively for the benefit of the patient. The amount of available funding may be reduced or eliminated if it is not credited by the patient’s health plan toward the patient’s out-of-pocket obligations (eg, deductibles, annual out-of-pocket maximums). Program funding may also be reduced or eliminated if the patient’s health plan, directly or indirectly, adjusts, reduces, or waives the patient’s health plan benefits based on the availability of, or the patient’s enrollment in, the Program, or otherwise acts in a manner that materially affects these Terms and Conditions.
Only the patient or their legal guardian or caregiver may enroll the patient in the Program. Health plans, specialty pharmacies, pharmacy benefit managers, and their agents and representatives (individually and collectively “Plan Administrators”), are prohibited from enrolling patients in the Program.
Patients in the Program are responsible for notifying Novartis of any change in their prescription drug health plan coverage that may conflict or otherwise affect compliance with these Terms and Conditions. By accepting Program funding from Novartis on behalf of participating patients, Plan Administrators agree to not take any action that materially affects compliance with these Terms and Conditions.
Patients may not seek reimbursement for the value received from the Program from any other party (eg, health plans, flexible spending or healthcare savings accounts). Patients are responsible for complying with any applicable limitations and requirements of their health plan related to their use of the Program.
Valid only in the United States and Puerto Rico. Co-pay support for infusion administration cost not available in Rhode Island or Massachusetts.
The Program is not health insurance, and may not be combined with any third-party rebate, coupon, or offer. Novartis reserves the right to rescind, revoke, or amend the Program at any time without notice.
‡The Covered Until You're Covered Program is available for COSENTYX subcutaneous injection only. Eligible patients must have private insurance, a valid prescription for COSENTYX, and a denial of insurance coverage based on a prior authorization request. Program requires the submission of an appeal of the coverage denial within the first 90 days of enrollment in order to remain eligible. Program provides COSENTYX for free to eligible patients for up to two years, or until they receive insurance coverage approval, whichever occurs earlier. A valid prescription consistent with FDA-approved labeling is required. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Patients may be asked to reverify insurance coverage status during the course of the program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Limitations may apply. Enrolled patients awaiting coverage for COSENTYX after two years may be eligible for a limited Program extension. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.